- Trade Name: Primacor (Sanofi-Aventis)
- Indications: Severe congestive heart failure unresponsive to conventional maintenance therapy; acute heart failure, including low output states following cardiac surgery.
- Class: Phosphodiesterase inhibitor
- Half-life: 2.3 hours
- Clinically important, potentially hazardous interactions with:
Anagrelide
Please login to view the rest of this drug profile.
Page last updated 08/20/2025
